The global cervix uteri malignant neoplasms mortality share shows a significant concentration of female deaths in Brazil, United States, Mexico, and Japan. Brazil leads with a share of 22.57% followed by the United States at 13.75%. Many European countries such as Poland, Romania, and Portugal exhibit negative growth rates, indicating a decline in mortality rates. In contrast, Latin American countries like Peru and Costa Rica demonstrate substantial increases with 2.5% and 4.34% growth respectively. Luxemberg's notable year-on-year increase at 14.87% despite a minor global share indicates potential concerns.
Future trends suggest a possible shift in the mortality share landscape, driven by healthcare improvements in certain regions and emerging challenges in others. Latin America may continue to show fluctuations, influenced by socioeconomic factors, while developed nations could see stabilization or declines due to advancements in medical interventions. Monitoring demographic shifts and healthcare policy changes will be essential to understanding these evolving trends.
Top countries in Cervix Uteri Malignant Neoplasms Mortality Share by Country (Units (Female Deaths))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Brazil | 22.57 | 2023 | +1.9% | +1.53% | View data |
| 2 | 2 United States | 13.75 | 2023 | +0.47% | +0.71% | View data |
| 3 | 3 Mexico | 13.4 | 2023 | +0.89% | +0.7% | View data |
| 4 | 4 Japan | 9.52 | 2023 | +0.75% | +0.69% | View data |
| 5 | 5 Colombia | 6 | 2023 | +1.03% | +1.86% | View data |
| 6 | 6 Poland | 4.75 | 2023 | -1% | -1.43% | View data |
| 7 | 7 Romania | 4.69 | 2023 | -0.95% | -0.068% | View data |
| 8 | 8 Argentina | 4.49 | 2023 | +3.01% | +1.62% | View data |
| 9 | 9 Peru | 4.17 | 2023 | +1.48% | +2.5% | View data |
| 10 | 10 United Kingdom | 2.79 | 2023 | +0.23% | +0.3% | View data |
